BeyondSpring

PriceBeyondSpring

BYSI

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

Historical stock price chart and annual return over the past years

-90%

5 years

% Total

BYSI
-37%

5 years

Annual Return

BYSI